UK markets closed

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.8200-0.0500 (-1.74%)
At close: 04:00PM EDT
2.8200 0.00 (0.00%)
After hours: 04:08PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-8,731
-3,415
-9,516
-288
-7,810
-
Depreciation & amortisation
7,058
6,998
7,575
7,621
7,632
-
Deferred income taxes
569
336
-414
-330
-23
-
Stock-based compensation
4,895
5,000
4,411
4,169
3,647
-
Change in working capital
7,604
4,600
2,716
-10,190
4,106
-
Accounts receivable
2,437
810
4,780
-4,294
3,105
-
Inventory
1,199
1,524
252
-5,861
413
-
Accounts payable
3,174
555
-1,399
-
511
-2,048
Other working capital
10,812
11,717
-438
-83
7,929
-
Other non-cash items
280
280
-3,620
280
1,180
-
Net cash provided by operating activities
13,619
14,028
1,152
1,262
9,331
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,807
-2,311
-1,590
-1,345
-1,402
-
Acquisitions, net
-
-
-
-
-
0
Other investing activities
-
-
-
-
-250
-15
Net cash used for investing activities
-2,312
-1,799
-1,590
-1,345
-1,402
-
Cash flows from financing activities
Debt repayment
-14,223
-15,041
-9,586
-4,200
-66,912
-
Other financing activities
-2,414
-2,523
-1,628
-3,616
-3,039
-
Net cash used provided by (used for) financing activities
-10,296
-12,134
-2,837
-252
-7,967
-
Net change in cash
466
-225
-3,313
-496
-18
-
Cash at beginning of period
3,789
4,508
7,821
8,317
8,335
-
Cash at end of period
4,800
4,283
4,508
7,821
8,317
-
Free cash flow
Operating cash flow
13,619
14,028
1,152
1,262
9,331
-
Capital expenditure
-2,807
-2,311
-1,590
-1,345
-1,402
-
Free cash flow
10,812
11,717
-438
-83
7,929
-